LBI-HTA - Publications - Search - Percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy (HOCM)

Wild, C. (2013): Percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy (HOCM) . Decision Support Document 71.

[img]PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
657Kb
Abstract

Hypertrophic cardiomyopathy (HCM) is a rare primary myocardial disease with a prevalence of 0.2%. HCM is hereditary and frequently appears in fa-milial clusters. In a portion of the patients (approx. 70%) it results, under exertion, to an obstruction of the left ventricular outflow tract: hypertrophic-obstructive cardiomyopathy/HOCM. HOCM is associated with sudden car-diac death. In addition to conventional methods (medicines), interventional or operative methods are also applied in the treatment of symptomatic HOCM patients.

Item Type:Decision Support Document
Subjects:WO Surgery > WO 500-517 Operative surgical procedures. Techniques
WG Cardiovascular system
QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
Language:German
Series Name:Decision Support Document 71
Deposited on:29 Jul 2013 14:07
Last Modified:29 Jul 2013 14:07

Repository Staff Only: item control page